Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  ISIS Pharmaceuticals, Inc.    ISIS   US4643301090

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/20/2015 04/21/2015 04/22/2015 04/23/2015 04/24/2015 Date
65.16(c) 66.29(c) 66.26(c) 67.745(c) 66.37(c) Last
1 459 720 2 175 674 1 366 930 1 455 690 1 747 594 Volume
-0.26% +1.73% -0.05% +2.24% -2.03% Change
More quotes
Financials ($)
Sales 2015 225 M
EBIT 2015 -82,5 M
Net income 2015 -99,5 M
Finance 2015 376 M
Yield 2015 -
Sales 2016 290 M
EBIT 2016 -45,3 M
Net income 2016 -65,8 M
Finance 2016 532 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 34,2x
EV / Sales 2016 26,0x
Capitalization 8 063 M
More Financials
Company
Isis Pharmaceuticals, Inc. engages in the development and commercialization of antisense drug discovery platform.It operates through the Drug Discovery and Development segment which exploits a novel drug discovery platform created to generate a broad pipeline of first-in-class drugs for the company... 
More about the company
Surperformance© ratings of ISIS Pharmaceuticals, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ISIS PHARMACEUTICALS, INC.
04/22 ISIS PHARMACEUTICALS : Reports Positive Data From ISIS-TTR Rx in Patients With T..
04/16 ISIS PHARMACEUTICALS : Patent Issued for Compounds and Methods for Improving Cel..
04/10 ISIS PHARMACEUTICALS : to Present at Upcoming Investor Conferences
03/27 ISIS PHARMACEUTICALS : Earnings Coverage - Isis Pharma
03/23 ISIS PHARMACEUTICALS : Earns $9M for Advancing ISIS-SMN Rx in Infants With Spina..
03/23 ISIS PHARMACEUTICALS : Reports Positive Phase 1 Data on Isis-ANGPTL3Rx
03/19 ISIS PHARMACEUTICALS : Cold Spring Harbor Laboratory, Isis Pharmaceuticals Assig..
03/18 INTERLEUKIN GENETICS : Expands its Collaboration with Isis Pharmaceuticals for G..
More news
Sector news : Biotechnology & Medical Research - NEC
04/23 MEDIVATION : Announces First Quarter 2015 Financial Results Teleconference on Ma..
04/23 ALKERMES : to Host Conference Call to Discuss First Quarter 2015 Financial Resul..
04/23DJAbbVie Profit Rises on Broad Sales Growth -- Update
More sector news : Biotechnology & Medical Research - NEC
4-Traders Strategies on ISIS PHARMACEUTICALS, INC. 
2014A resistance as obstacle
More Strategies
News from SeekingAlpha
08:02a IDERA PHARMACEUTICALS : Is The Writing On The Wall?
04/23 Alnylam Strengthens Its Clinical Case Once Again
04/06 Isis And Durect Foray Into NASH; Durect Is The Better Bet
03/26 Pfizer Is An Outright Buy - Cramer's Lightning Round (3/25/15)
03/17 PC Related Means Sell - Cramer's Lightning Round (3/16/15)


Comments 
Advertisement
Chart ISIS PHARMACEUTICALS, INC.
Duration : Period :
ISIS Pharmaceuticals, Inc. Technical Analysis Chart | ISIS | US4643301090 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF